Please login to the form below

Not currently logged in
Email:
Password:

cilengitide

This page shows the latest cilengitide news and features for those working in and with pharma, biotech and healthcare.

Glioblastomas - a personalised future?

Glioblastomas - a personalised future?

Another angiogenesis inhibitor, cilengitide, is in phase 3 development in Germany and the US in combination with temozolomide and radiation therapy, in newly diagnosed patients, and phase 2 in Germany in

Latest news

More from news
Approximately 1 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera

We live in a time of participation – patients actively involved in their own care recover faster and live longer....

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics